Background: Haptocorrin (HC) is a cobalamin (Cbl) transport protein known to recognize a wide range of corrinoids.
Results: We solved the crystal structure of human HC in complex with Cbl and cobinamide.
Conclusion: HC recognizes corrinoids by establishing distinct contacts with the corrin ring.
Significance: Our findings complete the molecular details for corrinoid recognition by human Cbl transport proteins.
Keywords: Biosynthesis, Crystal Structure, Metabolism, Nutrition, Vitamins, Cofactors, Cobalamin, Cobinamide, Corrinoids, Haptocorrin
Abstract
Cobalamin (Cbl; vitamin B12) is an essential micronutrient synthesized only by bacteria. Mammals have developed a sophisticated uptake system to capture the vitamin from the diet. Cbl transport is mediated by three transport proteins: transcobalamin, intrinsic factor, and haptocorrin (HC). All three proteins have a similar overall structure but a different selectivity for corrinoids. Here, we present the crystal structures of human HC in complex with cyanocobalamin and cobinamide at 2.35 and 3.0 Å resolution, respectively. The structures reveal that many of the interactions with the corrin ring are conserved among the human Cbl transporters. However, the non-conserved residues Asn-120, Arg-357, and Asn-373 form distinct interactions allowing for stabilization of corrinoids other than Cbl. A central binding motif forms interactions with the e- and f-side chains of the corrin ring and is conserved in corrinoid-binding proteins of other species. In addition, the α- and β-domains of HC form several unique interdomain contacts and have a higher shape complementarity than those of intrinsic factor and transcobalamin. The stabilization of ligands by all of these interactions is reflected in higher melting temperatures of the protein-ligand complexes. Our structural analysis offers fundamental insights into the unique binding behavior of HC and completes the picture of Cbl interaction with its three transport proteins.
Introduction
Cobalamin (Cbl4; vitamin B12) is an essential micronutrient synthesized only by microbes. It is a cofactor for the enzymes methionine synthase and methylmalonyl-CoA mutase. Consequently, Cbl is indispensable for central metabolic reactions, including biosynthetic pathways of nucleotides, branched-chain amino acids, and odd-chain fatty acids (1, 2). Therefore, Cbl deficiency has severe consequences, including anemia and impaired function of the nervous system (3). Cbl is a very complex metalorganic compound (4). It consists of a corrin ring with seven amide side chains (a–g), coordinating a central cobalt ion through four nitrogen atoms. The fifth coordination site on the lower axial part (α-side) of the molecule is provided by a 5,6-dimethylbenzimidazole (DMB) ribonucleotide moiety connected to side chain f, whereas the sixth coordination site (β-side) can be occupied by various ligands such as a cyano (CN), hydroxyl, methyl, or 5′-deoxyadenosyl group (see Fig. 1A).
FIGURE 1.
Chemical structure of corrin ligands and crystal structure of CNCbl bound to HC. A, structural formula of CNCbl with the labels A–D for the corrin ring and a–f for the side chains. B, chemical structure of Cbi. C, ribbon representation of HC (white) in complex with CNCbl. The CNCbl molecule is displayed in pink stick representation. The β3-β4 hairpin is highlighted in green. The critical residues for interaction with the α-side of CNCbl are shown in stick representation. The disordered linker is drawn as a dashed gray line. The dashed box depicts the area shown in more detail in E. D, interactions at the α5-β5-β6 site. The structures of HC-CNCbl (pale green), TC (dark gray), and IF (light gray) are in ribbon representation and are superimposed on their β-domains. Critical residues at the interdomain interface are shown in stick representation and are labeled. Secondary structure elements involved in the contact are labeled in blue. E, close-up view of the α-side interactions observed in HC. For clarity, only the three interacting hairpin residues are highlighted in green. Water molecules are shown as red spheres, and hydrogen bonds are shown as dashed black lines. F, close-up view of the interaction observed at the β-side between HC and CNCbl. The critical binding residues are shown in stick representation and are labeled in corresponding colors. Water molecules are depicted as red spheres. A polyethylene glycol molecule (crystallization buffer component) is shown in stick representation. The SigmaA-weighted 2mFo − DFc (gray mesh) and mFo − DFc (green and red mesh) electron density maps defining the CNCbl molecule are contoured at 1.0σ and ±3.0σ, respectively. G, critical interactions at the e- and f-side chains of CNCbl viewed from the β-side. The same color code is used as in A–C. Hydrogen bonds are depicted as dashed black lines.
A complex transport and uptake system has evolved to guarantee efficient assimilation of the minute amounts of Cbl present in dietary sources. Three proteins with similar structure mediate transport and distribution of Cbl in the human body by capturing the ligand with very high affinity (Kd ∼ 6 fm) (5, 6): intrinsic factor (IF), transcobalamin (TC), and haptocorrin (HC). Protein-bound Cbl is taken up by several receptors to cross cellular membranes (7–11). IF is responsible for the absorption of dietary Cbl in the intestine, and TC mediates Cbl transport from the blood to peripheral cells. HC binds Cbl in the upper part of the gastrointestinal tract and is responsible for the stomach passage (8). HC is present in secretions, including saliva, milk, and tears, but also in blood plasma (12). There, its physiological function is still unclear. A prominent feature of HC is its high content of glycans, which contribute 28% to the molecular weight. Depending on the source of synthesis (gastric mucosa, glands, granulocytes, etc.) (13), different glycoforms of HC have been described (14). In contrast, TC completely lacks glycans.
One striking difference between HC and the other two transport proteins is its ability to capture corrinoids other than Cbl, so-called Cbl analogs, with equally high affinity (15). Notably, HC even binds corrinoids whose nucleotide is missing (cobinamide (Cbi)) (see Fig. 1B) or not coordinated to the cobalt (“base-off” ligands) (6, 16). This suggests that HC has a potential role as a scavenger protein in plasma, preventing the uptake of biologically inactive corrinoids into cells and clearing them through the hepatobiliary pathway (16, 17). In fact, ∼40% of the corrinoids in blood plasma are Cbl analogs (18, 19). The exact nature and significance of these Cbl analogs in blood are still unclear, but interestingly, some studies found a correlation of high analog concentrations in blood with Cbl deficiency, neurologic abnormalities, and Alzheimer disease (12).
In the last 6 years, the crystal structures of human TC and bovine (bTC) TC (20), IF (21), and IF in complex with its receptor cubilin (22) have been reported. However, structural information on HC revealing the molecular determinants of the unique ability of HC to bind to Cbl analogs is still missing to date. Based on homology models, it was predicted that the overall architecture of HC is very similar to the structures of TC and IF (23). The ability of HC to bind the baseless ligand Cbi was explained by the presence of three bulky residues, Arg-357, Trp-359, and Tyr-362 (23), in the binding pocket. It is thought that these residues facilitate the binding of Cbi to HC by compensating for the absence of nucleotide at the α-side of the corrin ring. They may provide comparable hydrophobic contacts with the apolar α-side of Cbi, as observed for the DMB ribonucleotide in Cbl. In contrast to HC, TC and IF possess only one of these three bulky amino acids (Tyr and Trp, respectively) and thus cannot fully compensate for the hydrophobic contacts at the α-side of Cbi as proposed for HC. Still, the homology model did not provide an explanation for the ability of HC to bind a wide range of Cbl analogs modified at the α-side, including base-off ligands.
In this study, we set out to determine the crystal structure of HC to understand the molecular details of its unique corrinoid-binding behavior compared with the other reported Cbl transport proteins. To facilitate crystallization of the heavily glycosylated protein, we expressed recombinant human HC in HEK293 GnTI− cells, thereby producing proteins with a uniform glycosylation pattern to facilitate subsequent deglycosylation. We describe the crystal structures of HC in complex with the ligands cyanocobalamin (CNCbl) and Cbi. Our results complete the picture of corrinoid transport by providing the molecular details of the last of the three human transport proteins.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Recombinant human HC and TC (referred to below as HC and TC) and murine TC (mTC) were prepared as described previously (24, 25). Briefly, HC was expressed in HEK293 cells, purified on a nickel-nitrilotriacetic acid affinity column, and subjected to size exclusion chromatography using a Superdex 200 column equilibrated in 100 mm HEPES (pH 7.5) and 20 mm NaCl. Purification tags were removed by thrombin (Sigma) cleavage. For crystallization, the protein was expressed in HEK293 GnTI− cells, and additional steps were included in the purification procedure to increase the homogeneity of the protein sample. After thrombin cleavage and the second Ni2+ affinity column purification, the buffer was exchanged to 50 mm citric acid at pH 5.5 (12 mm citric acid and 38 mm sodium citrate) for deglycosylation overnight at room temperature on an orbital shaker using either endoglycosidase H (5 units; New England Biolabs) or endoglycosidase F1 (10 μg/mg protein; New England Biolabs). The sample was then finally polished on a HiLoadTM 16/60 Superdex 200 column at a flow rate of 48 ml/h using HEPES-buffered saline at pH 7.4 (20 mm HEPES (pH 7.4) and 100 mm NaCl). The fractions with pure and untagged protein were pooled, concentrated to 36 mg/ml, and directly used for crystallization. Recombinant IF was kindly provided by Prof. Ebba Nexø (Aarhus University Hospital, Aarhus, Denmark).
Differential Scanning Fluorometry (DSF)
A real-time PCR cycler (Rotor-Gene Q 5plex HRM, Qiagen) was used for protein stability measurement by DSF. Stability measurements were performed in triplicates in PBS at pH 7.4. SYPRO® Orange (Invitrogen) was used at a 5-fold final concentration. The final protein concentration in the samples was 1 μm, and the ligand concentration was varied between 0.25 and 10 μm. The final volume of the samples was 100 μl. The real-time PCR cycler was programmed to ramp the temperature from 25 to 95 °C, collecting the data every 0.5 °C, with an equilibration time of 2 s. Data were normalized to the peak fluorescence value of the protein in the absence of ligands. Tm values were determined using Rotor-Gene Q Version 2.0.2.4 software (Qiagen).
Crystallization and Structure Determination
For crystallization, proteins were supplied with a 1.5-fold molar excess of CNCbl (Sigma) or dicyanocobinamide (Sigma) and concentrated to 0.8 mm (36 mg/ml). Proteins were mixed in a 1:1 ratio with the precipitant and crystallized by the sitting drop vapor diffusion technique at a temperature of 4 °C. Hexagonal pink crystals appeared in 50% PEG 400, 0.2 m MgCl2, and 0.1 m sodium cacodylate (pH 6.5) after 5–7 days and reached their full size after 15 days. They belonged to space group P64, with one molecule in the asymmetric unit. Crystals were flash-cooled in liquid nitrogen without additional cryoprotecting agents.
Diffraction data were collected at 100 K at beamline X06SA of the Swiss Light Source (Villigen, Switzerland). Data were processed and merged using XDS (26). The structure of HC-CNCbl was determined by molecular replacement with Phaser (27) using the individual domains of the structures of human IF (chain A, Protein Data Bank code 2PMV) and bTC (chain A, code 2BB6) as search models, after mutation of the side chains with CHAINSAW (25, 28) and after removal of the flexible loops. The initial molecular replacement solution (RFZ (rotation function Z-score) = 5.4, TFZ (translation function Z-score) = 15.0, LLG (log-likelihood gain) = 205, RFZ = 3.9, TFZ = 12.2, LLG = 289) was first fitted by rigid body refinement, followed by automated model rebuilding with PHENIX (29). The resulting model was further completed by iterative cycles of refinement with TLS (translation/libration/screw) in PHENIX and manual rebuilding in Coot (30). The CNCbl ligand was manually placed in the difference map and included in the final rounds of refinement. The structure of HC-Cbi was determined by molecular replacement using the refined CNCbl model as template. Data collection and refinement statistics are provided in Table 1. The quality of the structures was analyzed with MOLPROBITY (31), and figures were prepared using PyMOL Version 1.5.0.4 (Schrödinger LLC).
TABLE 1.
Data collection and refinement statistics
| HC-CNCbl | HC-Cbi | |
|---|---|---|
| Data collectiona | ||
| Space group | P64 | P64 |
| Cell dimensions | ||
| a, b, c (Å) | 149.9, 149.9, 57.5 | 150.4, 150.4, 60.3 |
| Resolution (Å) | 49.0-2.35 (2.4-2.35) | 49.2-3.0 (3.1-3.0) |
| Rmeas (%)b | 10.1 (156.1) | 5.8 (176.2) |
| Rpim (%)c | 3.5 (49.4) | 2.0 (66.4) |
| CChalfd | 99.8 (68.9) | 100.0 (62.6) |
| 〈I〉/〈σI〉 | 13.6 (1.9) | 28.5 (1.4) |
| Completeness (%) | 100 (100) | 100 (100) |
| Redundancy | 10.2 (10.6) | 10.3 (10.8) |
| Refinement | ||
| Resolution (Å) | 49.0-2.35 | 49.2-3.0 |
| No. of unique reflections | 31,012 (1565 in test set) | 15,820 (795 in test set) |
| Rwork/Rfree (%) | 19.6/22.6 | 20.3/25.2 |
| Average B-factors (Å2) | ||
| Complex | 59.6 | 88.5 |
| Solvent | 66.6 | 60.9 |
| Ligand | 43.2 | 72.9 |
| Wilson B-factor | 55.1 | 105.7 |
| No. of atoms | ||
| Protein | 3116 | 3116 |
| Solvent (including PEG) | 211 | 10 |
| Ligand | 93 | 77 |
| Glycans | 98 | 98 |
| r.m.s.d.e from ideality | ||
| Bond length (Å) | 0.002 | 0.003 |
| Bond angles | 0.683° | 0.730° |
| Ramachandran statistics (%)f | ||
| Favored regions | 95.7 | 94.4 |
| Allowed regions | 3.8 | 5.0 |
| Outliers | 0.5 | 0.5 |
a Highest shell statistics are in parentheses.
b Rmeas = Σhkl√(N/(N − 1))Σi|Ii(hkl) − 〈I(hkl)〉|/ΣhklΣiIi(hkl). Redundancy-independent R-factor, where 〈I(hkl)〉 is the average of symmetry-related observations of a unique reflection, and each reflection contribution is adjusted by a factor of √(N/(N − 1)), where N is the multiplicity (36).
c Rpim = Σhkl√(1/(N − 1))Σi|Ii(hkl) − 〈I(hkl)〉|/ΣhklΣiIi(hkl). Precision-indicating merging R-factor, which describes the precision of the averaged measurement (37).
d CChalf = percentage of correlation between intensities from random half-data sets, as defined by Karplus and Diederichs (35).
e r.m.s.d., root mean square deviation.
f As defined by MOLPROBITY (31).
RESULTS
Overall Structure of HC
Crystals of HC in complex with the two ligands CNCbl and Cbi (Fig. 1, A and B) were obtained, and the structures of the complexes were determined to 2.35 and 3.0 Å resolution, respectively. In both complexes, the ligands are buried at the interdomain interface. Here, we compared the HC-CNCbl structure with the reported structures of IF-CNCbl (21) and TC-H2O-Cbl (20). Despite the low sequence identity (<25%) to TC and IF (23), HC features a very similar domain architecture. It comprises two globular domains, the N-terminal α-domain (residues 1–287) and the C-terminal β-domain (residues 309–410), which are connected by a flexible linker (Figs. 1C and 2).
FIGURE 2.
Structure-based multiple sequence alignment of Cbl transport proteins. The secondary structure elements of HC are drawn on top of the sequences. Identical residues are shaded in red, and highly conserved residues are shown in red. Critical residues for ligand interaction with HC are shown in pink and green boxes, respectively. The cysteine residues forming the four disulfide bridges in HC are labeled in green at the bottom of the aligned sequences. The numbers correspond to disulfide bridges 1–4. The alignment was generated using ESPript Version 2.2. hTC, human TC.
The α-domain consists of an intertwined α6/α6 helical barrel as described for TC (20) and IF (21). However, conformational differences are observed at the α1-α2, α3-α4, and α5-α6 loops, which are remote from the ligand interaction site. The α3-α4 loop is much shorter than in TC and is more similar to the corresponding loop in IF. Moreover, the α4-α5 loop of HC adopts a helical conformation (α5′). The outer shell helix α7 is shortened by a helix break at Pro-149, which is followed by a long α7-α8 loop containing a short β-hairpin (β-1′-β-1″ (Fig. 1F). The 3/10 helix capping the bottom of the barrel is one turn shorter than observed in TC and IF. The three disulfide bridges (Cys-3–Cys-242, Cys-82–Cys-285, and Cys-132–Cys-174) that cross-link the α-domain are also conserved.
The β-domain consists of two almost perpendicular antiparallel β-sheets (β1/β2/β6/β7/β8 and β3/β4/β5) and an α-helix (α13) stacked in between (20). The tight hydrophobic packing is further stabilized by an additional fourth disulfide bridge (Cys-365–Cys-370), which is unique to human HC and is absent in both TC and IF. This disulfide bridge reduces the flexibility of the β5-β6 loop, which adopts a similar conformation as observed in the structure of IF and which contains a two-residue insertion (Asn-373 and Asn-374) compared with TC (Fig. 1D). This two-residue insertion at the tip of the β5-β6 turn establishes a contact with helix α5 and the α5-α6 loop of the α-domain and confers additional stability to the complex. It comprises the side chains of Asn-109, His-113, Thr-116, Lys-152, Asn-153, Asn-373, Asn-374, and Arg-376 and the main chains of Asn-114, Leu-118, and Thr-119 (Fig. 1D), which form three direct and a series of water-mediated hydrogen bonds. In TC and IF, this interaction is less prominent due to a shorter β5-β6 loop (TC) and a shorter helix α5 (in IF, two turns shorter, and TC, one turn shorter), which is tilted away from the β-domain (Figs. 1D and 2). In TC, no direct hydrogen bonds are observed at this interdomain contact, and in IF, only one salt bridge (Lys-365–Glu-110) and one hydrogen bond (Lys-365–Ser-105) have been described (21).
Clear electron density for seven N-linked N-acetylglucosamine moieties is present in the HC-CNCbl structure at Asn-193, Asn-293, Asn-314, Asn-320, Asn-326, Asn-331, and Asn-346. In contrast to the crystal structure of human TC, the HC linker does not participate in crystal contacts over its full length and is largely disordered (residues 296–307). Linker residues 289–294 form a parallel β-strand interaction with strand β2 of a symmetry-related molecule (residues 321–325). Moreover, the N-glycan at Asn-293 is in contact with the symmetry-related N-glycans at Asn-326 and Asn-346. This explains why HC crystallized only upon deglycosylation, as longer branched glycans at these three sites would have prevented crystal formation (data not shown).
The relative orientation between the α-and β-domains in HC varies compared with TC and IF: the central axis of the α-domain of HC relative to the β-domain is tilted by 16° compared with TC and is both tilted and twisted by 12° compared with IF. These differences result in a tighter packing of the HC-ligand complex, which features a total buried surface area of 1491 Å2 compared with 1166, 1254, and 1266 Å2 for TC, bTC, and IF, respectively. Accordingly, the overall structure of HC superimposes on TC, bTC, and IF with root mean square deviations of 2.3 Å (281 Cα atoms), 2.3 Å (302 Cα atoms), and 1.8 Å (246 Cα atoms) Å, respectively. The individual domains align to a higher extent: the α-domains superimpose with root mean square deviations of 1.8 Å (TC, 183 Cα atoms), 2.0 Å (bTC, 200 Cα atoms), and 1.2 Å (IF, 159 Cα atoms), and the β-domains superimpose with root mean square deviations of 0.7 Å (TC, 71 Cα atoms), 1.0 Å (bTC, 86 Cα atoms), and 0.8 Å (IF 82 Cα atoms).
Binding of CNCbl to HC
The CNCbl molecule is bound at the α/β-domain interface, with the corrin ring plane oriented almost parallel to the central axis of the helical barrel (Fig. 1C). The cobalt ion is coordinated by the four nitrogen atoms of the corrin ring, the N3B atom of the DMB ring, and a CN molecule at the sixth coordination site. The hydrogen bonds formed with side chains a, c, d, and g of the corrin ring are generally conserved among the three transport proteins (Fig. 1, E–G, and Table 2). Main-chain amides and/or carbonyls of β-domain residues (Leu-381, Leu-388, Ile-363, and Trp-379) form hydrogen bonds with side chains c and d, whereas amino acid side chains of the α-domain (Asp-163, Asn-217, and Gln-266) interact with side chains a and g through hydrogen bonds. As observed for IF, HC does not form any direct hydrogen bonds with the b-side chain. The most striking differences among the three transport proteins are found in the contacts that are formed with side chains e and f. In addition to the two conserved hydrogen bonds formed by Thr-119 and Gln-123 with the e- and f-side chains, respectively, HC forms unique contacts with both the e- and f-side chains with the three residues Asn-120, Tyr-410, and Asn-373 (Fig. 1, E and G; Fig. 3, A and B; and Table 2), which are not conserved in TC and IF (Fig. 2). Similar to TC and IF, the corrin ring is further stabilized by hydrophobic interactions with amino acid side chains, including Tyr-122, Phe-219, Trp-359, and Tyr-378 (Fig. 1, E and F).
TABLE 2.
Interactions of human Cbl transport proteins with their ligands
| Cbl atom | HC | TC | IF |
|---|---|---|---|
| Side chain a | |||
| O28 | Asn-217 Nδ | Asn-224 Nδ | |
| N29 | Asn-217 Oδ, Asp-163 Oδ1 | Asn-224 Oδ, Asp-176 Oδ2 | Asp-204 Oδ1/Oδ2, Asp-153 Oδ1 |
| Side chain b | |||
| O33 | |||
| N34 | (Leu-388 O) | ||
| Side chain c | |||
| O39 | Leu-381 N | Leu-379 N | |
| N40 | Leu-381 O, Leu-388 O | Leu-379 O, Leu-387 O | Phe-370 O, Leu-377 O |
| Side chain d | |||
| O44 | Ile-363 N | (Leu-363 N) | Val-352 N |
| N45 | Ile-363 O, Trp-379 O | Leu-363 O, (Trp-377 O) | Val-352 O |
| Side chain e | |||
| O51 | Asn-120 N | ||
| N52 | Thr-119 O, (Tyr-410 Oη), Asn-373 Oδ1 | Thr-134 O | |
| Side chain f | |||
| O58 | Gln-123 Nϵ, Asn-120 N | Gln-138 Nϵ | |
| N59 | |||
| Side chain g | |||
| O62 | Gln-266 Nϵ | (Gln-273 Nϵ), (Tyr-137 Oη) | Gln-252 Nϵ, Τyr-115 Oη |
| N63 | Gln-266 Oϵ, Asp-163 Oδ1 | Gln-273 Oϵ, Asp-176 Oδ2 | Gln-252 Oϵ, Asp-153 Oδ1 |
| Nucleotide arm | |||
| O4 | Gln-86 Nϵ | His-73 Nϵ | |
| O5 | Leu-358 N | Ser-374 Oγ | |
FIGURE 3.
Cbl ligand recognition by HC compared with TC and IF. To compare the details of ligand recognition, the structures were superimposed on the corrin rings of their ligands. A and B, superposition of bTC (gray; Protein Data Bank code 2BB6) and IF (gray; code 2PMV), respectively, onto HC viewed from the β-side of the corrin ring. HC residues are labeled in black, and TC and IF residues are labeled in gray. In the absence of the side chains of Asn-120 and Asn-373, three hydrogen bonds cannot be formed to the ligand. C, stabilization of the α-side of CNCbl in HC compared with human TC (light gray; Protein Data Bank code 2BB6). The β3-β4 hairpin of HC is highlighted in green. The critical residues for interaction with the α-side of CNCbl are shown in stick representation. Water molecules are shown as red spheres, and hydrogen bonds as shown as green (HC) and black (TC) dashed lines. The CNCbl molecule is displayed in pink, and the Cbl molecule is shown in light gray stick representation. D, stabilization of the α-side of CNCbl in HC compared with IF (light gray; Protein Data Bank code 2PMV). The representation details are the same as in C. E–G, interactions at the β-side of the corrin ring of HC compared with human TC, bTC, and IF, respectively. HC is shown in green schematic representation. The compared structures are superimposed in white. Critical residues are shown in stick representation and are labeled.
At the α-side of the corrin ring, the β-hairpin residue Arg-357 forms a water-mediated hydrogen bond with the ring oxygen of the ribose moiety of CNCbl (Fig. 1E and Fig. 3, C and D). This interaction is unique to HC because this amino acid is not conserved in IF and TC (Fig. 2). Together with the side chains of Trp-359 and Tyr-362, it further stabilizes the DMB ribonucleotide moiety by hydrophobic contacts. The stabilization of the α-side is complemented by a series of water-mediated hydrogen bonds with the phosphoryl moiety formed by the main-chain amides of the β-hairpin and by Glu-71 and Gln-123 of the α-domain (Fig. 1E and Fig. 3, C and D).
At the tip of the β-1′-β-1″ hairpin, the side chain of Phe-156 laterally stabilizes the CN moiety of the ligand on the β-side by a hydrophobic contact. Moreover, one polyethylene glycol and three water molecules fill up the cavity of the β-side (Fig. 1F). In TC, a histidine (His-173 in human TC and His-175 in bTC) (20) coordinates the cobalt ion of Cbl (Fig. 3, E and F), whereas in IF, the sixth coordination site of Cbl is empty, devoid of any ordered water molecules (Fig. 3G) (21). In the absence of the CN moiety, we cannot exclude that the side chain of Phe-156 gets reoriented to coordinate the cobalt ion by a cation-π interaction.
Binding of Cbi to HC
To understand the molecular details that permit the binding of a baseless corrinoid to HC, we determined the crystal structure of HC in complex with Cbi (Fig. 1B). Compared with CNCbl binding, no differences are observed at the β-side. The corrin ring of Cbi is stabilized by the same interactions as described for CNCbl (Fig. 4A). Of particular importance are the interactions observed at the e-side chain of Cbi. In addition to a density observed for the CN moiety at the α-side of Cbi, additional density is present in the proximity of the CN moiety, which accounts for the presence of an alternate conformation of the e-propionamide side chain (Fig. 4B). This alternate conformation fills up the space otherwise occupied by the DMB ribonucleotide moiety and orients the e-propionamide ideally to form a hydrogen bond to the guanidine group of Arg-357.
FIGURE 4.

Specificity determinants for Cbi binding. A, stabilization of the e- and f-side chains of Cbi viewed from the β-side. The structure of HC is shown as a white schematic, and the ligand Cbi is shown in yellow stick representation. Critical hydrogen bond interactions are highlighted as dashed lines. B, e-side chain flip at the lower axial side of Cbi. The e-propionamide can adopt two different conformations. The flip-in conformation is further stabilized by two hydrogen bonds with Arg-357 and the CN molecule. The SigmaA-weighted 2mFo − DFc (gray mesh) and mFo − DFc (green and red mesh) electron density maps defining the Cbi molecule are contoured at 1.0σ and ±3.0σ, respectively. The green mesh defines the region occupied by the alternate conformation of the e-side chain. C, alignment of the central motif from different species interacting with the e- and f-side chains of the corrin ring. Residues that form hydrogen bonds are indicated in red.
DSF
We used DSF to analyze the ability of the ligands CNCbl and Cbi to stabilize HC, IF, TC, and mTC. mTC was included in these studies because it has been shown to recognize Cbi (32). Briefly, proteins were mixed with different concentrations of ligands, and thermal unfolding upon temperature increase was monitored. Whereas HC and mTC have been described to bind both ligands, IF and TC recognize only Cbl with high affinity (6, 32). Reported kinetic binding studies observed similar affinities of the three human transport proteins for CNCbl (6). CNCbl binding induced very high thermal shifts (ΔTm) of >23.5 ± 0.04 °C in HC and 26.3 ± 0.03 °C in mTC (Fig. 5, A and G). Interestingly, much lower ΔTm values of 7.7 ± 0.2 °C and 13.9 ± 0.2 °C were observed for IF and TC, respectively (Fig. 5, C and E). ΔTm values were concentration-independent at ligand concentrations of >2 μm (Fig. 5, insets), which corresponds to a protein/ligand ratio of at least 1:2.
FIGURE 5.
Thermal stabilization of transport proteins by Cbl (left) or Cbi (right) binding. The concentration of the added ligand is indicated by the different colors. Filled areas indicate the standard deviation of triplicate experiments. Insets show ΔTm values depending on ligand concentration. A and B, human HC; C and D, human IF; E and F, human TC; G and H, mTC.
The baseless corrinoid Cbi induced significantly lower ΔTm values in all four proteins (Fig. 5, B, D, F, and H). Notably, no thermal shift could be detected upon binding to IF, even at a 10-fold excess of the ligand. Again, HC and mTC had very similar ΔTm values of 15.9 ± 0.3 °C and 16.1 ± 0.1 °C, respectively. Only a very low thermal stabilization of 3.1 ± 0.1 °C was observed for TC.
DISCUSSION
It is well known that HC is the least specific Cbl transport protein, binding to a diversity of Cbl derivatives and analogs (13, 16). However, the molecular details that confer this broad ligand tolerability to HC are poorly understood. Our studies provide a rational explanation for the high affinity binding of HC to a variety of corrinoids.
DSF demonstrated that not only Cbi but also CNCbl binding resulted in higher thermal stabilization of HC and mTC compared with the Cbl-specific transport proteins IF and TC. These results corroborate our structural findings that corrinoid recognition by HC generally differs compared with IF and TC and that the important determinants are involved in the binding of both Cbl and Cbi. We identified several structural features that explain the ability of HC to bind a wide range of corrinoids.
Most important, additional hydrogen bonds formed by the non-conserved residues Asn-120 and Asn-373 with both the e- and f-side chains of the corrin ring stabilize even ligands with a missing or modified DMB ribonucleotide moiety. Although in TC the e- and f-side chains are stabilized by only one hydrogen bond each (Thr-134 and Gln-138), no hydrogen bond formation with these side chains is found in IF (Fig. 6). The better stabilization of the e- and f-side chains by a protein is reflected in (i) the ability of corrinoid ligands to induce higher thermal shifts and (ii) a lower selectivity of the protein for Cbl.
FIGURE 6.

Hydrogen bond interactions with CNCbl. Hydrogen bonds are indicated as dotted or dashed lines. Thick dashed lines are unique for HC. A, in HC, both the α- and β-domains form hydrogen bonds with the e-side chain; e- and f-side chains are additionally stabilized by Asp-120. B, TC forms hydrogen bonds via both the α-and β-domains with the phosphate group, but only the α-domain stabilizes the e-side chain. C, IF does not form any hydrogen bonds with either the e- or f-side chain. As in TC, both domains form hydrogen bonds with the phosphate group.
Recent studies showed that HC is present in most mammals (33). Interestingly, in species lacking HC, including mice and lower vertebrates, a TC-like protein has been shown to be less specific for Cbl and to recognize Cbi and other corrinoids, similar to human HC (32–34). According to the sequence alignment (Figs. 2 and 4C), Asn-135 in mTC corresponds to Asn-120 in human HC and is in a position to form the analogous hydrogen bonds with the e- and f-side chains. Furthermore, Asn-120 is also conserved in the sole Cbl transport protein described for some fish species (Fig. 4C). This protein is able to bind Cbi and was named HIT because it features some characteristics of HC, IF, and TC (34). Indeed, not only Asn-120 but also the entire binding motif … TNYYQ … , which forms four hydrogen bonds with e- and f-side chains, is conserved in fish HIT and mTC (Fig. 4C). We conclude that conservation of this binding motif is indicative of binding proteins that are able to recognize corrinoids other than Cbl. HC forms two additional hydrogen bonds with side chain e through Asn-373 and Tyr-410, but these interactions are not found in the binding proteins of fish and mice.
In the case of the baseless corrinoid Cbi, additional structural features of HC may contribute to stabilization of the ligand. First, Arg-357 stabilizes the flip-in conformation of Cbi in HC with a hydrogen bond that cannot occur in the other transport proteins. Second, at the lower side of Cbi, the three bulky side chains of Arg-357, Trp-359, and Tyr-362 provide hydrophobic and polar contacts with the corrin ring and stand in for the lacking base. Although the three large hydrophobic residues Arg-357, Trp-359, and Tyr-362 have already been identified as a possible feature for binding to the nucleotide-lacking Cbi (23), the role of Arg-357 in stabilizing the flip-in conformation of Cbi was not predicted. However, the three bulky residues are not a prerequisite for Cbi binding because only one of them is conserved in mTC.
Finally, the relative α/β-domain orientation varies among HC, TC, bTC, and IF and leads to variable tight packing of the domains. The larger buried surface area in HC accounts for more interactions and even more shape complementarity between the two domains and is another molecular determinant that leads to the observed large differences in thermal shifts for HC compared with the other human Cbl transport proteins. Based on our analysis, it is likely that the stabilization of the protein-ligand complex not only occurs through electrostatic interactions but is augmented by higher shape complementarity in HC and the interdomain contact between α5 and the β5-β6 loop.
Here, we have reported the crystal structure of the third human Cbl transport protein, HC, which has the unique ability to bind a wide range of corrinoids. The function of this protein in blood plasma and secretions is still obscure. Knowing the molecular determinants that contribute to corrinoid recognition could help to improve our understanding of the complex transport system by which the human body mediates different fates for the valuable vitamin Cbl and its potentially harmful analogs.
Acknowledgments
We thank Marie-Sophie Rotter and Dmitry Veprintsev for excellent technical assistance.
This work was supported by Swiss National Science Foundation Grant 31003A-112455, Novartis Foundation for Medical-Biological Research Grant 10C74 (to A. E. P.), and the Research Committee (FoKo) of the Paul Scherrer Institut (to E. F.).
The atomic coordinates and structure factors (codes 4KKI and 4KKJ) have been deposited in the Protein Data Bank (http://wwpdb.org/).
- Cbl
- cobalamin
- DMB
- 5,6-dimethylbenzimidazole
- CN
- cyano
- IF
- intrinsic factor
- TC
- transcobalamin
- bTC
- bovine TC
- mTC
- murine TC
- HC
- haptocorrin
- Cbi
- cobinamide
- CNCbl
- cyanocobalamin
- DSF
- differential scanning fluorometry.
REFERENCES
- 1. Banerjee R., Ragsdale S. W. (2003) The many faces of vitamin B12: catalysis by cobalamin-dependent enzymes. Annu. Rev. Biochem. 72, 209–247 [DOI] [PubMed] [Google Scholar]
- 2. Carmel R., Green R., Rosenblatt D. S., Watkins D. (2003) Update on cobalamin, folate, and homocysteine. Hematology Am. Soc. Hematol. Educ. Program 2003, 62–81 [DOI] [PubMed] [Google Scholar]
- 3. Wolters M., Ströhle A., Hahn A. (2004) Cobalamin: a critical vitamin in the elderly. Prevent. Med. 39, 1256–1266 [DOI] [PubMed] [Google Scholar]
- 4. Randaccio L., Geremia S., Demitri N., Wuerges J. (2010) Vitamin B12: unique metalorganic compounds and the most complex vitamins. Molecules 15, 3228–3259 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Fedosov S. N., Grissom C. B., Fedosova N. U., Moestrup S. K., Nexø E., Petersen T. E. (2006) Application of a fluorescent cobalamin analogue for analysis of the binding kinetics. A study employing recombinant human transcobalamin and intrinsic factor. FEBS J. 273, 4742–4753 [DOI] [PubMed] [Google Scholar]
- 6. Fedosov S. N., Fedosova N. U., Kräutler B., Nexø E., Petersen T. E. (2007) Mechanisms of discrimination between cobalamins and their natural analogues during their binding to the specific B12-transporting proteins. Biochemistry 46, 6446–6458 [DOI] [PubMed] [Google Scholar]
- 7. Allen R. H. (1975) Human vitamin B12 transport proteins. Progr. Hematol. 9, 57–84 [PubMed] [Google Scholar]
- 8. Fedosov S. N. (2012) Physiological and molecular aspects of cobalamin transport. Subcell. Biochem. 56, 347–367 [DOI] [PubMed] [Google Scholar]
- 9. Moestrup S. K. (2006) New insights into carrier binding and epithelial uptake of the erythropoietic nutrients cobalamin and folate. Curr. Opin. Hematol. 13, 119–123 [DOI] [PubMed] [Google Scholar]
- 10. Nexø E. (1998) Cobalamin binding proteins. in Vitamin B12 and B12-Proteins (Kräutler B., Arigoni D., Golding B. T., eds) pp. 461–475, Wiley-VCH Verlag GmbH, Weinheim, Germany [Google Scholar]
- 11. Nielsen M. J., Rasmussen M. R., Andersen C. B., Nexø E., Moestrup S. K. (2012) Vitamin B12 transport from food to the body's cells–a sophisticated, multistep pathway. Nat. Rev. Gastroenterol. Hepatol. 9, 345–354 [DOI] [PubMed] [Google Scholar]
- 12. Morkbak A. L., Poulsen S. S., Nexø E. (2007) Haptocorrin in humans. Clin. Chem. Lab. Med. 45, 1751–1759 [DOI] [PubMed] [Google Scholar]
- 13. Alpers D. H., Russell-Jones G. (1999) Intrinsic factor, haptocorrin, and their receptors. in Chemistry and Biochemistry of B12 (Banerjee R., ed) pp. 411–440, Wiley, New York [Google Scholar]
- 14. Yang S. Y., Coleman P. S., Dupont B. (1982) The biochemical and genetic basis for the microheterogeneity of human R-type vitamin B12 binding proteins. Blood 59, 747–755 [PubMed] [Google Scholar]
- 15. Kolhouse J. F., Allen R. H. (1977) Absorption, plasma transport, and cellular retention of cobalamin analogues in the rabbit. Evidence for the existence of multiple mechanisms that prevent the absorption and tissue dissemination of naturally occurring cobalamin analogues. J. Clin. Invest. 60, 1381–1392 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Stupperich E., Nexø E. (1991) Effect of the cobalt-N coordination on the cobamide recognition by the human vitamin B12 binding proteins intrinsic factor, transcobalamin and haptocorrin. Eur. J. Biochem. 199, 299–303 [DOI] [PubMed] [Google Scholar]
- 17. Burger R. L., Schneider R. J., Mehlman C. S., Allen R. H. (1975) Human plasma R-type vitamin B12-binding proteins. II. The role of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein in the plasma transport of vitamin B12. J. Biol. Chem. 250, 7707–7713 [PubMed] [Google Scholar]
- 18. Kolhouse J. F., Kondo H., Allen N. C., Podell E., Allen R. H. (1978) Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin. N. Engl. J. Med. 299, 785–792 [DOI] [PubMed] [Google Scholar]
- 19. Hardlei T. F., Nexø E. (2009) A new principle for measurement of cobalamin and corrinoids, used for studies of cobalamin analogs on serum haptocorrin. Clin. Chem. 55, 1002–1010 [DOI] [PubMed] [Google Scholar]
- 20. Wuerges J., Garau G., Geremia S., Fedosov S. N., Petersen T. E., Randaccio L. (2006) Structural basis for mammalian vitamin B12 transport by transcobalamin. Proc. Natl. Acad. Sci. U.S.A. 103, 4386–4391 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Mathews F. S., Gordon M. M., Chen Z., Rajashankar K. R., Ealick S. E., Alpers D. H., Sukumar N. (2007) Crystal structure of human intrinsic factor: cobalamin complex at 2.6-Å resolution. Proc. Natl. Acad. Sci. U.S.A. 104, 17311–17316 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Andersen C. B., Madsen M., Storm T., Moestrup S. K., Andersen G. R. (2010) Structural basis for receptor recognition of vitamin-B12-intrinsic factor complexes. Nature 464, 445–448 [DOI] [PubMed] [Google Scholar]
- 23. Wuerges J., Geremia S., Randaccio L. (2007) Structural study on ligand specificity of human vitamin B12 transporters. Biochem. J. 403, 431–440 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Furger E., Fedosov S. N., Lildballe D. L., Waibel R., Schibli R., Nexø E., Fischer E. (2012) Comparison of recombinant human haptocorrin expressed in human embryonic kidney cells and native haptocorrin. PLoS ONE 7, e37421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Furger E. (2012) Structural and Functional Characterisation of the Cobalamin Transport Protein Haptocorrin. Ph.D. thesis, ETH Zürich [Google Scholar]
- 26. Kabsch W. (2010) XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. McCoy A. J., Grosse-Kunstleve R. W., Adams P. D., Winn M. D., Storoni L. C., Read R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Winn M. D., Ballard C. C., Cowtan K. D., Dodson E. J., Emsley P., Evans P. R., Keegan R. M., Krissinel E. B., Leslie A. G., McCoy A., McNicholas S. J., Murshudov G. N., Pannu N. S., Potterton E. A., Powell H. R., Read R. J., Vagin A., Wilson K. S. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Adams P. D., Afonine P. V., Bunkóczi G., Chen V. B., Davis I. W., Echols N., Headd J. J., Hung L. W., Kapral G. J., Grosse-Kunstleve R. W., McCoy A. J., Moriarty N. W., Oeffner R., Read R. J., Richardson D. C., Richardson J. S., Terwilliger T. C., Zwart P. H. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Emsley P., Cowtan K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 [DOI] [PubMed] [Google Scholar]
- 31. Davis I. W., Murray L. W., Richardson J. S., Richardson D. C. (2004) MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 32, W615–W619 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Hygum K., Lildballe D. L., Greibe E. H., Morkbak A. L., Poulsen S. S., Sorensen B. S., Petersen T. E., Nexø E. (2011) Mouse transcobalamin has features resembling both human transcobalamin and haptocorrin. PLoS ONE 6, e20638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Greibe E., Fedosov S., Nexø E. (2012) The cobalamin-binding protein in zebrafish is an intermediate between the three cobalamin-binding proteins in human. PLoS ONE 7, e35660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Greibe E., Fedosov S., Sorensen B. S., Højrup P., Poulsen S. S., Nexø E. (2012) A single rainbow trout cobalamin-binding protein stands in for three human binders. J. Biol. Chem. 287, 33917–33925 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Karplus P. A., Diederichs K. (2012) Linking crystallographic model and data quality. Science 336, 1030–1033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Diederichs K., Karplus P.A. (1997) Improved R-factors for diffraction data analysis in macromolecular crystallography. Nat. Struct. Biol. 4, 269–275 [DOI] [PubMed] [Google Scholar]
- 37. Weiss M. S. (2001) Global indicators of X-ray data quality. J. Appl. Cryst. 34, 130–135 [Google Scholar]




